CRYO-CELL INTERNATIONAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value of $0.00 per share for the 9-month period ending 2018-08-31, per its 10-Q filed 2018-10-15.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue · last filed 2018-10-15
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2018-02-28 was $0.00.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2017-02-28 was $0.00.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2016-02-29 was $0.00.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for the quarter ending 2015-02-28 was $0.00, a 100.00% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2017 was $0.00.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2016 was $0.00.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- CRYO-CELL INTERNATIONAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2014 was $1.81, a 4.23% decline from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2018-08-31 | $0.00 10-Q · filed 2018-10-15 | |||
| 2018-05-31 | $0.00 10-Q · filed 2018-07-16 | |||
| 2018-02-28 | $0.00 10-Q · filed 2018-04-16 | |||
| 2017-11-30 | $0.00 10-K · filed 2018-02-28 | |||
| 2017-08-31 | $0.00 10-Q · filed 2017-10-16 | |||
| 2017-05-31 | $0.00 10-Q · filed 2017-07-07 | |||
| 2017-02-28 | $0.00 10-Q · filed 2017-04-13 | |||
| 2016-11-30 | $0.00 10-K · filed 2017-02-28 | |||
| 2016-08-31 | $0.00 10-Q · filed 2016-10-17 | |||
| 2016-05-31 | $0.00 10-Q · filed 2016-07-11 | |||
| 2016-02-29 | $0.00 10-Q · filed 2016-04-14 | |||
| 2015-11-30 | $0.00 10-K · filed 2016-02-29 | |||
| 2015-08-31 | $0.00 10-Q · filed 2015-10-15 | |||
| 2015-05-31 | $0.00 10-Q · filed 2015-07-15 | |||
| 2015-02-28 | $0.00 10-Q · filed 2015-04-14 | |||
| 2014-11-30 | $1.81 10-K · filed 2015-03-02 | |||
| 2014-08-31 | $1.82 10-Q · filed 2014-10-15 | |||
| 2014-05-31 | $1.84 10-Q · filed 2014-07-03 | |||
| 2014-02-28 | $1.76 10-Q · filed 2014-04-14 | |||
| 2013-11-30 | $1.89 10-K · filed 2014-02-28 | |||
| 2013-08-31 | $1.84 10-Q · filed 2013-10-15 | |||
| 2013-05-31 | $1.86 10-Q · filed 2013-07-15 | |||
| 2013-02-28 | $1.96 10-Q · filed 2013-04-15 | |||
| 2012-11-30 | $1.65 10-K · filed 2013-02-28 | |||
| 2012-08-31 | $1.63 10-Q · filed 2012-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |